Safi Biotherapeutics Inc
United States
- Greater Boston, MA
- 13/09/2024
- Seed
- $5,000,000
Safi Biotherapeutics is an early-stage biotech company developing manufactured red blood cell (mRBC) therapies from stem cells
- Industry Biotechnology
- Website https://safi.bio/
- LinkedIn https://www.linkedin.com/company/safi-biotherapeutics-inc/
Related People
Doug McConnellCo Founder
United States -
Cambridge, Massachusetts
Biopharmaceutical entrepreneur and executive leader. Successful building, leading, and optimizing operational and strategic functions from R&D through to commercial launch.
Areas of expertise:
• Building Highly Effective Teams:
Formed and led 20 person cross-organizational team to establish company’s first non-US, non-European legal entity and R&D operations site in a challenging and evolving emerging global market
• Program, Portfolio and Alliance Management:
Established effective R&D portfolio reporting following successful implementation of MS Project Server environment, with appropriate standards and integrated master and functional plans
• Strategic Planning & Decision-Making:
Effectively integrated key R&D portfolio information into the Corporate Planning process to support effective decision-making
• Managing Organizational Change:
Translated defined strategies into executable, global operational plans while taking a mindful approach to proactively identifying and managing the impacts and opportunities of the organizational change
• Cross-Organizational Process Optimization:
Created and led a new clinical operations excellence unit that streamlined and optimized all clinical trial processes in less than 12 months to successfully support critical pre-NDA inspections
• Business Systems Implementation:
Business lead for the rapid implementation and adoption of a regulatory document management system in under 12 months to support company’s initial NDA submission
Vesence | $9,000,000 | (Oct 30, 2025)
Sparrow BioAcoustics | $10,000,000 | (Oct 30, 2025)
Reflectiz | $22,000,000 | (Oct 30, 2025)
Mem0 | $24,000,000 | (Oct 30, 2025)
Valthos | $30,000,000 | (Oct 30, 2025)
Mondra | $13,206,500 | (Oct 30, 2025)
hoop.dev | Undisclosed Amount | (Oct 30, 2025)
IORGANBIO | $2,000,000 | (Oct 30, 2025)
FrontlineIQ | $3,300,000 | (Oct 30, 2025)
Homecourt | $8,000,000 | (Oct 30, 2025)
VentureMed Inc. | $28,000,000 | (Oct 30, 2025)
Recess | $30,000,000 | (Oct 30, 2025)